Pharmaceuticals, Biotechnology and Life Sciences
Winner to be Presented at BIO-Europe 2024 in Stockholm, SwedenROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE…
IBSRELA generates $40.6 million in net product sales revenue; Company expects full year 2024 IBSRELA net sales revenue to be between…
Iovance also to Participate in Upcoming November ConferencesSAN CARLOS, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ:…
Acquisition strengthens Lyell’s clinical pipeline with the addition of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate expected to initiate…
WATERTOWN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing…
WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that…
Photo caption: Rwanda Minister of State for Health, Yvan Butera, was among those who received Sabin’s investigational vaccine in the…
Includes initial funding of approximately $5 million, as well as the option for additional proceeds of approximately $5 millionNEW YORK,…
-New testing method highlights link between protofibrils and biomarkers for neurodegeneration–Patient and caregiver perspectives on five-year treatment with lecanemab —…
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…